Click here to access the new analysis clearly showing you the advantage of doing what is proposed.

There is certainly change in the wind in relation to funded lamotrigine in the future.

PHARMAC have notified that effective 1 October 2019 there will be one fully funded brand.

There is a 5 month transition period from 1 May 2019 to 30 September 2019 where all existing brands will remain listed, fully funded at existing schedule prices.

This provides a small window of opportunity for pharmacy to make additional margin for a period of time leading up to the 30 September 2019. Yes all patients will need to transition to the sole supply brand Logem to have fully funded Lamotrigine, but not immediately.

About The Author